Douglas Kerr
CIK 1814189 · Chief Medical Officer · last filed 2026-05-14
Douglas Kerr is a Chief Medical Officer who has filed 26 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $28.7K of DYN on May 14, 2026. Across all open-market trades the lifetime net is −$1.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.09M
2
26
-$1.71M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Chief Medical Officer | 170,042 | $18.19 | $3.09M | -$153.1K | 10 | 2026-05-14 |
| Generation Bio Co. (GBIO) Delisted | CHIEF MEDICAL OFFICER | 385,628 | $5.34 | $2.06M | -$1.55M | 16 | 2024-01-31 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | DYN | Sell (S) | −1,564 | -$28.7K | EDGAR |
| 2026-03-06 | DYN | Sell (S) | −904 | -$13.5K | EDGAR |
| 2026-02-17 | DYN | Grant (A) | +85,000 | $0 | EDGAR |
| 2025-12-05 | DYN | Sell (S) | −880 | -$18.2K | EDGAR |
| 2025-09-08 | DYN | Sell (S) | −4,425 | -$58.8K | EDGAR |
| 2025-07-18 | DYN | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | DYN | Sell (S) | −1,342 | -$17.9K | EDGAR |
| 2025-03-07 | DYN | Sell (S) | −1,343 | -$15.9K | EDGAR |
| 2024-12-06 | DYN | Grant (A) | +48,000 | $0 | EDGAR |
| 2024-09-03 | DYN | Grant (A) | +47,500 | $0 | EDGAR |